| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &General Counsel | EVP &General Counsel
1 company
Mahon Paul A is an EVP &General Counsel at UNITED THERAPEUTICS Corp. Recent SEC Form 4 filings include 0 buys and 31 sells.
Estimated insider holdings value: $20.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 2,500 | $243.87 | $609,675.00 | -6.4% | -5.7% | +34.7% | |
| Jul 6, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $215.19 | $1,291,165.31 | -3.9% | +4.2% | +47.7% | |
| Jun 15, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $227.77 | $1,366,634.23 | -7.4% | -3.2% | +25.5% | |
| Jun 1, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $209.11 | $1,254,677.48 | -4.8% | +7.0% | +28.9% | |
| May 18, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $214.58 | $1,287,472.93 | -7.3% | +6.4% | +26.5% | |
| May 4, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $215.82 | $1,294,903.37 | -3.8% | +11.6% | +21.6% | |
| Apr 20, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $223.96 | $1,343,754.52 | -5.1% | +7.6% | +5.7% | |
| Apr 6, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $232.79 | $1,396,754.96 | -4.9% | -3.4% | +2.8% | |
| Mar 16, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $214.39 | $1,286,342.45 | -3.0% | +2.8% | +7.1% | |
| Mar 2, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $242.57 | $1,455,417.61 | -3.8% | -14.3% | -5.2% |